Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

Recent studies have shown that haploidentical hematopoietic stem cell transplantation supported by third-party cord blood (haplo-cord-HSCT) results in rapid hematopoietic recovery, low incidences of graft-versus-host disease (GVHD), and relapse of hematologic malignancies. However, few reports on ha...

Full description

Bibliographic Details
Main Authors: Tingting Cheng, Yan Chen, Yi Liu, Xia Ma, Cong Zeng, Xu Chen, Shiyu Wang, Yajing Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
haploidentical donor
peripheral blood
cord blood
stem cell transplantation
HLA-matched sibling donor
hematologic malignancy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.922120/full

Similar Items

Similar Items